SALES FORECAST: The U.K. pharmaceutical company is expected to report sales of 7.8 billion pounds ($10.42 billion), according to consensus estimates compiled by the company. For last year's second ...

We expect Moderna MRNA to surpass expectations when it reports second-quarter 2025 earnings on Aug. 1, before the opening ...

Relief over a US-EU trade deal today benefited the FTSE 100 index in a session when leading European benchmarks rose by as ...

Discover how Obexelimab's unique B-cell inhibition and pivotal Phase 3 IgG4 results could drive Zenas BioPharma, Inc.'s ...

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

Asian equities were mostly higher overnight as Vietnam and Indonesia outperformed while Japan and India underperformed. Hong ...

With the stock's last traded price at Rs 3,081, GlaxoSmithKline Pharmaceuticals has experienced a notable decline, positioning it among the top losers on the Nifty Midcap 150 index.

As the earnings season progresses, results from heavyweights such as NTPC, Tata Steel, Hindustan Unilever, Mahindra & ...

Earnings season hits full stride next week, with an expansive slate of reports from tech titans, energy giants, financial ...

Check Anthem Biosciences Stock Price live NSE/BSE on financialexpress.com. Get Anthem Biosciences today's stock price, 52-week high, 52-week low, Anthem Biosciences quarterly results, share ...

Pakistan’s pharmaceutical sector stands as one of the steadily growing industries within the country’s economy.

The stock traded 9% higher after the company’s core business posted revenue growth ahead of consensus expectations.